An update on testosterone, HDL and cardiovascular risk in men-Reference-Cited by-同舟云学术

An update on testosterone, HDL and cardiovascular risk in men

Published:2015-06-01 Issue:3 Volume:10 Page:251-258
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Thirumalai Arthi¹,Rubinow Katya B²,Page Stephanie T³

Affiliation:

1. University of Washington, Division of Metabolism, Endocrinology & Nutrition, 1959 NE Pacific Street, Box 356426, Seattle, WA 98195, USA

2. University of Washington, Division of Metabolism, Endocrinology & Nutrition, South Lake Union Campus, 850 Republican Street, Box 358055, Seattle, WA 98109, USA

3. University of Washington, Division of Metabolism, Endocrinology & Nutrition, 1959 NE Pacific Street, Box 357138, Seattle, WA 98195, USA

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.15.10

Reference55 articles.

1. Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metabol. 95(6), 2536–2559 (2010).

2. Haddad RM, Kennedy CC, Caples SM et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin. Proc. 82(1), 29–39 (2007). • Meta-Analysis Of 30 Randomized Trials That Concluded That Testosterone Therapy In Men With Androgen Deficiency Was Not Associated With Cardiovascular Events.

3. Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. N. Engl. J. Med. 363(2), 109–122 (2010). •• Randomized Controlled Trial That Was Stopped Early Due To Higher Cardiovascular Events In Elderly, Frail Men With A High Prevalence Of Chronic Disease.

4. Wu FC, Von Eckardstein A. Androgens and coronary artery disease. Endocrine Rev. 24(2), 183–217 (2003).

5. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH, Channer KS. Low serum testosterone and increased mortality in men with coronary heart disease. Heart 96(22), 1821–1825 (2010).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Blood Lipids Following Initiation of Gender Affirming Hormone Therapy: A Systematic Review and Meta-Analysis;Journal of Clinical & Translational Endocrinology;2024-06

2. Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism;The Journal of Clinical Endocrinology & Metabolism;2024-04-12

3. Anabolic steroids induced changes at the level of protein expression: Effects of prolonged administration of testosterone and nandrolone to pigs;Environmental Toxicology and Pharmacology;2024-04

4. Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men;Journal of Lipid Research;2024-03

5. Title: Clinical and Biochemical Outcomes in Transgender Individuals Undergoing Hormone Therapy: A Systematic Review Protocol (Preprint);JMIR Research Protocols;2024-02-29